In the findings, CKIε was upregulated in AML and ALL patients compared to healthy individuals; thereby, it is possible to have the same oncogenic function as reported in other cancerous malignancies, showing its potential function as a biomarker in leukemia [91]. This evidence concerns the gene CSNK1E and acute myeloid leukemia.